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Little is known about how health behaviors and receipt of prevent-
ive health care differ by race and ethnicity among prostate cancer
survivors. The purpose of this study was to identify differences in
the prevalence of 7 modifiable factors related to prostate cancer:
smoking,  alcohol  consumption,  physical  inactivity,  weight,
colorectal cancer screening, influenza vaccination, and pneumo-
coccal vaccination.
Methods
We used data from the 2010 Behavioral Risk Factor Surveillance
System to calculate the racial/ethnic prevalence of sociodemo-
graphic and health-related characteristics, health behaviors, and
preventive health care among prostate cancer survivors. Adjusted
prevalence estimates were calculated by using multivariable lo-
gistic regression.
Results
We identified 8,016 men with a history of prostate cancer. Mul-
tivariable analyses indicated that more black men reported being
obese (29.9%; 95% confidence interval [CI], 24.5%–35.9%) than
white  men (22.8%;  95% CI,  21.1%–24.6%).  More  white  men
(3.6%; 95% CI, 2.9%–4.5%) reported consuming more than 2 al-
coholic  drinks  per  day  than  black  men  (0.9%;  95%  CI,
0.4%–2.0%). More white men aged 65 or older reported receiving
pneumococcal vaccine (74.2%; 95% CI, 72.2%–76.1%) than black
men of the same age (63.2%; 95% CI, 54.8%–70.8%).We did not
observe any differences in the prevalence of health behaviors and
preventive health care between white men and men in Hispanic or
other race categories.
Conclusion
Differences  in  alcohol  consumption,  obesity,  and  receipt  of
pneumococcal vaccination existed only between black and white
prostate cancer survivors. These differences underscore the need
to develop culturally appropriate, evidence-based interventions to
reduce excessive alcohol consumption, maintain a healthy weight,
and promote pneumococcal vaccination among prostate cancer
survivors.
Introduction
Because of widespread prostate cancer screening, advances in can-
cer diagnosis and treatment, and the slow-growing nature of most
prostate cancers, cancer survival rates have improved substan-
tially (1). By the end of 2011, the number of prostate cancer sur-
vivors approached 2.8 million and accounted for 44% of all US
male cancer survivors (2). The number of prostate cancer surviv-
ors is expected to increase over time because of population aging
(2).
Studies have consistently shown that unhealthy behaviors, such as
poor diet, physical inactivity, and cigarette smoking, increase the
risk of prostate cancer recurrence, secondary cancers, other chron-
ic  diseases,  and death  (3).  Prostate  cancer  survivors  are  more
likely to  die  of  comorbid diseases  than of  prostate  cancer  (4).
Thus, attention to health behaviors and preventive health care is an
important aspect of quality care for prostate cancer survivors. In
2014, the American Cancer Society released guidelines for care of
prostate cancer survivors to help survivors achieve optimal health
and quality of life (3).
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Although racial and ethnic differences in health behaviors and pre-
ventive health care have been well-documented among the gener-
al population (5), patterns may change after cancer diagnosis. To
our knowledge, racial/ethnic disparities have been studied among
breast cancer and colorectal cancer (CRC) cancer survivors but not
prostate cancer survivors (6). We assessed racial and ethnic differ-
ences in the prevalence of 7 risk factors — smoking, alcohol con-
sumption, physical inactivity, obesity, CRC screening, influenza
vaccination, and pneumococcal vaccination — that could indicate
opportunities  for  prevention  of  comorbid  diseases  and  death
among prostate cancer survivors. Cancer control planners could
use this information to tailor and prioritize public health interven-
tions by race and ethnicity to improve the health and well-being of
survivors.
Methods
The Behavioral Risk Factor Surveillance System (BRFSS) is an
ongoing, state-based, random-digit–dialed telephone survey of the
noninstitutionalized US civilian population aged 18 years or older
(http://www.cdc.gov/BRFSS/). The BRFSS collects information
about diseases, health-related behaviors, preventive health prac-
tices, and access to health care. We analyzed 2010 BRFSS data
from all 50 states and the District of Columbia. The median re-
sponse  rate  was  54.6%,  and  the  median  cooperation  rate  was
76.9% (7). Because this study analyzed secondary data from a
publicly accessible dataset, it did not require institutional review
board approval.
To identify prostate cancer survivors, we used the question, “Have
you ever been told by a doctor, nurse, or other health professional
that you had prostate cancer?” We restricted our analysis to men
aged 40 years or older who reported a history of prostate cancer,
because BRFSS did not collect prostate cancer information among
men younger than 40. We analyzed 4 racial and ethnic categories:
non-Hispanic  white  (hereafter,  “white”),  non-Hispanic  black
(hereafter, “black”), non-Hispanic other (includes Asian and Pa-
cific Islanders, American Indians and Alaska Natives, and others;
hereafter “other race”), and Hispanic.
We examined the following factors: demographics (age, educa-
tion level, employment status, and marital status), health care ac-
cess (health insurance status, medical cost concerns, having a usu-
al health care provider, and time since last checkup), and emotion-
al support. We classified emotional support into a 3-level variable:
always or usually, sometimes, and rarely or never in response to
the question, “How often do you get the social and emotional sup-
port you need?” We also identified chronic conditions, such as a
history of diabetes (all types), myocardial infarction, heart disease,
stroke, or current asthma. The status of these chronic conditions
were classified as a yes/no variable. We grouped the number of
chronic conditions into 4 categories: 0, 1, 2, and 3 or more. We
defined disability status as a yes/no variable on the basis of the
question, “Are you limited in any way in any activities because of
physical, mental, and emotional problems?”
We defined obesity as having a body mass index (BMI) of 30 kg/
m2 or higher. We dichotomized alcohol consumption into more
than 2 drinks per day or 2 drinks per day or less on the basis of
American Cancer Society recommendations for alcohol consump-
tion among prostate cancer survivors (3). We classified physical
inactivity status with yes or no answers to the question, “During
the past month, other than your regular job, did you participate in
any physical activities or exercise, such as running, calisthenics,
golf, gardening, or walking for exercise?” We identified current
cigarette smokers as adults who had smoked at least 100 cigar-
ettes during their lifetime and were smoking at the time the survey
was conducted.
On the basis of national vaccination recommendations and cancer
screening recommendations  (8–10),  we included 3  preventive
health service measures for age-eligible persons: up-to-date influ-
enza  vaccination,  pneumococcal  vaccination for  men aged 65
years or older, and CRC screening for men aged 50 to 75 years.
We determined the status of up-to-date influenza and pneumococ-
cal vaccinations with the following survey questions: “During the
past 12 months, have you had a seasonal flu shot?”; “During the
past  12 months,  have you had a seasonal  flu vaccine that  was
sprayed in your nose?”; and “Have you ever had a pneumonia
shot?” CRC screening was assessed according to US Preventive
Services Task Force recommendations as receipt of any of the fol-
lowing: fecal occult blood test within 1 year, sigmoidoscopy with-
in 5 years and fecal occult blood test within 3 years, or colono-
scopy within 10 years (9).
We calculated weighted percentage estimates with 95% confid-
ence intervals (CIs) for sociodemographic and health-related char-
acteristics, health behaviors, and use of preventive health care,
stratified by racial and ethnic group. Differences by racial and eth-
nic group were assessed by using the Pearson Wald F test. A mul-
tivariable logistic regression model was constructed to examine ra-
cial  and ethnic  differences in  health behaviors  and preventive
health care use after adjustment for sociodemographic and health-
related characteristics. We present the adjusted associations of
race and ethnicity with health behaviors and preventive health care
as percentages by using predictive margins. The predictive mar-
gin for a specific group represents the average predicted response
if everyone in the sample had been in that group (11). P values for
pairwise comparisons between white and other racial and ethnic
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groups were based on the Wald F test. We analyzed all data by us-
ing SAS, version 9.3 (SAS Institute, Inc) with SUDAAN, version
11.0.0 (RTI International) to account for complex sampling design
and to allow for weighted estimates. P values less than or equal to
.05 were deemed significant.
Results
Of 8,016 men interviewed for the 2010 BRFSS who reported a
history of prostate cancer, most were white (79.7%), followed by
black (11.2%), Hispanic (5.8%), and other race (3.3%). All so-
ciodemographic and health-related characteristics for prostate can-
cer survivors varied significantly by race and ethnicity (P ≤.05),
except having a usual health care provider (Table 1). Prevalence
rates of the following categories were highest among white men:
being aged 65 years or older, having health insurance, having few-
er medical cost concerns, having a usual health care provider, and
always having emotional support. White men (6.2%) had a lower
prevalence of unemployment than black men (11.1%) and Hispan-
ic men (18.8%). Men classified as other race had a higher preval-
ence of having a college degree and being married or living to-
gether than black men and Hispanic men. Hispanic men had a
higher prevalence of having less than a high school education
(40.1%) than white men (7.0%) and black men (21.6%).
Overall, there were significant racial and ethnic differences in his-
tories of diabetes, total number of chronic conditions, and disabil-
ity status (P ≤.05). Black men had a higher prevalence of diabetes
(33.7%) than white (18.6%) and Hispanic men (19.5%) (data not
shown). Men of other race had a higher prevalence of having 3 or
more chronic conditions (18.1%) than black men (3.5%) and white
men (5.3%).  White  men had a  higher  percentage of  disability
(36.0%) than Hispanic men (25.2%).
Significant racial or ethnic differences were observed in current ci-
garette  smoking status,  consumption of  more than 2 alcoholic
drinks per day, obesity, and receipt of influenza and pneumococ-
cal vaccines (P ≤.05) (Table 2). Black men had a higher preval-
ence of being current cigarette smokers (15.1%) than white men
(8.4%). Black men also reported a higher percentage of obesity
(33.2%) than white men (22.7%). Hispanic men (7.0%) and white
men (3.7%) reported higher percentages of consuming more than
2 drinks per day than did black men (0.8%).
After adjusting for sociodemographic and health-related character-
istics, multivariable logistic regression analyses (Table 3) indic-
ated that racial/ethnic differences remained significant for con-
suming more than 2 alcoholic drinks per day, obesity, and receipt
of pneumococcal vaccine. More black men reported being obese
(29.9%; 95% CI, 24.5%–35.9%) than white men (22.8%; 95% CI,
21.1%–24.6%). More white men (3.6%; 95% CI, 2.9%–4.5%) re-
ported consuming more than 2 alcoholic drinks per day than black
men (0.9%; 95% CI, 0.4%–2.0%). More white men aged 65 or
older reported receiving pneumococcal vaccine (74.2%; 95% CI,
72.2%–76.1%) than black men of the same age (63.2%; 95% CI,
54.8%–70.8%). We did not observe significant differences in the
prevalence of health behaviors and receipt of preventive health
care between white men and men of Hispanic or other race.
Discussion
By using the BRFSS, the largest telephone survey of prostate can-
cer survivors in the United States, we analyzed whether racial and
ethnic differences existed in 7 potential risk factors after prostate
cancer diagnoses. Although racial and ethnic differences were not
observed for physical inactivity, smoking, CRC screening, and in-
fluenza vaccination, we found that more white prostate cancer sur-
vivors reported drinking alcohol and receiving a pneumococcal
vaccination than black survivors; more black survivors reported
being obese than white survivors.
These differences among black and white populations have been
corroborated by previous studies focusing on the general US popu-
lation and breast cancer survivors. For example, Kanny and col-
leagues analyzed 2011 BRFSS data and reported that black adults
had a substantially lower prevalence of binge drinking (14.2%)
than white adults (21.1%) (12). In addition, White and colleagues
found that white breast cancer survivors were more likely to be
heavy alcohol drinkers (4.3%), but less likely to be obese (23.7%)
than black breast cancer survivors (0.9% and 32.3%, respectively)
(13). Likewise, among men aged 20 years or older participating in
a 2007–2008 national survey, prevalence of obesity was signific-
antly higher among blacks (37.3%) than whites (31.9%) (14).
More than one-third of US adults are obese (15). Although the link
between obesity and risk of prostate cancer is not well established,
studies suggested associations between obesity and prostate can-
cer-specific mortality and biochemical recurrence detected via
prostate-specific antigen test (16–19). In addition, a retrospective,
multi-institutional pooled analysis suggested that increased BMI
could partially account for the disparity in biochemical recurrence
of prostate cancer among black and white men (20). Overweight
and obesity are risk factors for many other chronic diseases and
conditions, including heart disease, hypertension, and diabetes.
Some of these conditions are common among prostate cancer sur-
vivors. In one study, 20.1% of survivors reported having heart dis-
ease, 58.3% reported hypertension, and 23.7% reported diabetes
(21). Because of the high prevalence of obesity and its adverse ef-
fects on prostate cancer outcomes and other chronic conditions,
the American Cancer Society suggests that primary care physi-
cians routinely assess BMI among prostate cancer survivors across
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their cancer survivorship continuum and recommends that surviv-
ors maintain a healthy weight (3). Differences in prostate cancer
mortality rates between black and white men was extensively stud-
ied in relationship to socioeconomic status, tumor characteristics,
treatment method, and quality of care (22–25). However, the role
that obesity may play in racial disparities in prostate cancer mor-
tality was not well studied.
Excessive alcohol consumption led to about 75,000 deaths in the
United States from 2006 through 2010, making it a leading cause
of premature death (26); however, excessive alcohol consumption
was not shown to increase the risk of prostate cancer (27). Associ-
ations between alcohol use and prostate cancer-specific deaths are
inconclusive (28). Alcohol should be avoided among prostate can-
cer survivors undergoing chemotherapy or biological treatments
because  of  an  increased  risk  of  side  effects  resulting  from
alcohol–medication interactions (27).
Studies showed that racial or ethnic minorities are less likely to
use preventive health care than whites (29,30). However, we did
not find any differences between blacks and whites for receipt of
CRC screening in our study. The Advisory Committee on Immun-
ization Practices recommends influenza and pneumococcal vac-
cines for adults who meet the eligibility criteria (8,10). We ob-
served significant racial/ethnic variation for receipt of pneumococ-
cal vaccine among prostate cancer survivors but not for receipt of
influenza vaccine. Palmer and colleagues examined 2006–2010
National Health Interview Survey data for male cancer survivors
and reported that among men aged 65 years or older, black men
were twice as likely as white men not to receive influenza vaccine
and pneumococcal vaccine (6). The discrepancy between our find-
ings for receipt of influenza vaccine and the findings of Palmer
and  colleagues  might  be  because  our  study  populations  were
younger (≥40 years)  than theirs (≥65 years).
Our study has several limitations. First, BRFSS data were self-re-
ported, and the findings may be subject to recall and social de-
sirability biases. Second, although our study used nationwide data,
BRFSS samples only noninstitutionalized US citizens with land-
line telephones. Cancer survivors who lived in prisons, nursing
homes, long-term care facilities, or hospice were excluded. Third,
we could not determine when cancer was diagnosed or whether
survivors were currently having symptoms of cancer or were cur-
rently being treated, because this information was not collected.
Fourth, racial/ethnic disparities in health behaviors and preventive
health care services may have been due to factors we did not in-
vestigate, such as daily servings of fruits and vegetables, the type
of health care provider from whom the respondent received ser-
vices (ie, from a primary care provider or from a specialist), treat-
ments and treatment-related comorbidities, and structural barriers
to adopting healthy behaviors. BRFSS does not collect this in-
formation. Fifth, the study was underpowered to examine prostate
cancer differences for Hispanics and other race; future studies
should include more Hispanics and other populations. Sixth, we
might have overestimated CRC screening rates, because some re-
ported tests could be used for diagnostic and surveillance pur-
poses. Finally, given the low response rate of 54.6% in the 2010
survey, our population-based estimates might reflect selection bi-
as. However, the calculations of probability weights, which were
adjusted for  differences in probability  of  selection and nonre-
sponse, might have partially corrected for any bias.
In conclusion, obesity and excessive alcohol use are preventable
causes of death and comorbidity among prostate cancer survivors
in the United States. The preventive health care service measures
included in this study (eg, vaccinations, CRC screening) are evid-
ence-based and cost-effective (8–10). Our study identified only
significant  differences  in  obesity,  alcohol  consumption,  and
pneumococcal vaccinations for black and white men, underscor-
ing the need to develop culturally appropriate, evidence-based in-
terventions to reduce excessive alcohol consumption, maintain a
healthy weight, and promote pneumococcal vaccinations among
prostate cancer survivors.
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Tables










% (95% CI) P Value
Age, y n = 6,886 n = 673 n = 205 n = 226
<.00140–64 23.0 (21.2–24.9) 34.5 (28.7–40.9) 39.4 (26.2–54.3) 38.5 (27.8–50.4)
≥65 77.0 (75.1–78.8) 65.5 (59.1–71.3) 60.6 (45.7–73.8) 61.5 (49.6–72.2)
Education level n = 6,894 n = 674 n = 203 n = 224
<.001
<High school 7.0 (6.1–8.0) 21.6 (16.5–27.6) 15.9 (7.2–31.7) 40.1 (29.2–52.2)
High school graduate 25.8 (24.2–27.5) 32.1 (26.5–38.3) 17.2 (10.5–26.9) 20.3 (12.9–30.4)
Some college 22.9 (21.3–24.7) 22.6 (18.0–28.0) 15.7 (8.8–26.6) 15.3 (9.8–23.0)
College graduate 44.2 (42.3–46.1) 23.7 (18.9–29.3) 51.1 (37.1–65.0) 24.3 (15.2–36.6)
Employment status n = 6,887 n = 674 n = 204 n = 225
.006
Employed 24.8 (23.0–26.7) 23.5 (18.4–29.5) 34.9 (21.4–51.3) 24.1 (15.2–35.9)
Not employed 6.2 (5.3–7.3) 11.1 (8.3–14.6) 9.6 (5.2–16.9) 18.8 (11.2–29.9)
Retired 69.0 (67.1–70.9) 65.5 (59.3–71.1) 55.6 (40.8–69.4) 57.2 (45.2–68.3)
Marital status n = 6,902 n = 675 n = 203 n = 225
<.001
Married or living together 77.8 (76.3–79.2) 66.3 (60.8–71.4) 82.0 (72.8–88.5) 57.9 (45.7–69.2)
Divorced, separated, or widowed 18.8 (17.5–20.2) 28.0 (23.3–33.2) 16.5 (10.2–25.5) 32.0 (22.0–44.1)
Never married 3.4 (2.8–4.0) 5.7 (3.9–8.3) 1.6 (0.7–3.3) 10.1 (3.9–23.6)
Health insurance n = 6,900 n = 675 n = 204 n = 226
.046Yes 97.9 (97.1–98.4) 94.6 (90.7–97.0) 88.8 (70.6–96.3) 92.1 (80.6–97.0)
No 2.1 (1.6–2.9) 5.4 (3.0–9.3) 11.2 (3.7–29.4) 7.9 (3.0–19.4)
Time since last checkup n = 6,843 n = 668 n = 199 n = 223
<.001
Within past year 86.9 (85.5–88.1) 90.3 (85.6–93.6) 85.9 (74.9–92.6) 81.6 (68.9–89.9)
≤2 years 7.3 (6.4– 8.4) 6.1 (3.5–10.3) 5.6 (2.3–12.9) 2.3 (0.9–5.3)
2–<5 years 2.8 (2.3–3.5) 2.7 (1.3–5.8) 1.8 (0.6–5.1) 9.2 (3.2–23.7)
≥5 years 2.7 (2.1–3.3) 0.9 (0.3–3.1) 6.1 (1.8–18.2) 3.5 (1.2–9.6)
Never 0.3 (0.2–0.5) 0.0 (.–.) 0.6 (0.1–2.4) 3.4 (0.8–13.3)
Medical cost concerns n = 6,896 n = 672 n = 205 n = 224
.001Yes 4.2 (3.4–5.0) 8.7 (6.1–12.4) 21.3 (10.5–38.4) 11.7 (6.3–20.7)
No 95.8 (95.0–96.6) 91.3 (87.6–93.9) 78.7 (61.6–89.5) 88.3 (79.3–93.7)
Has usual health care provider n = 6,894 n = 671 n = 205 n = 224
.12Yes 96.6 (95.9–97.3) 93.6 (89.5–96.2) 95.4 (86.2–98.6) 91.5 (83.0–95.9)
No 3.4 (2.7–4.1) 6.4 (3.8–10.5) 4.6 (1.4–13.8) 8.5 (4.1–17.0)
Emotional support n = 6,614 n = 636 n = 194 n = 213
<.001Always/usually 81.5 (80.0–82.9) 68.7 (62.5–74.2) 63.0 (48.3–75.6) 61.9 (49.4–72.9)
Sometimes 6.9 (6.0–7.9) 15.8 (11.8–20.9) 15.0 (6.8–30.0) 19.1 (10.8–31.5)
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; CI, confidence interval.
a Variations of total count by variable might be caused by “don't know,” refused, or missing responses.
b Chronic conditions included are diabetes, myocardial infarction, heart disease, and current asthma.
(continued on next page)
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(continued)










% (95% CI) P Value
Rare/none 11.7 (10.5–12.9) 15.5 (11.5–20.7) 22.0 (12.7–35.3) 19.1 (11.3–30.4)
Has chronic conditionsb n = 6,640 n = 648 n = 191 n = 219
<.001
0 58.5 (56.5–60.3) 43.4 (37.4–49.6) 47.5 (33.3–62.1) 62.2 (50.9–72.2)
1 24.6 (23.0–26.3) 37.1 (30.8–43.9) 24.3 (15.2–36.7) 25.5 (17.0–36.3)
2 11.6 (10.4–12.9) 15.9 (11.9–21.0) 10.1 (4.3–21.8) 5.0 (2.5–9.8)
≥3 5.3 (4.5–6.3) 3.5 (2.0–5.9) 18.1 (8.2–35.4) 7.4 (3.7–14.3)
Disability n = 6,873 n = 668 n = 203 n = 226
.02Yes 36.0 (34.2–37.9) 30.6 (25.0–36.8) 24.8 (14.3–39.4) 25.2 (17.2–35.4)
No 64.0 (62.1–65.8) 69.4 (63.2–75.0) 75.2 (60.6–85.7) 74.8 (64.6–82.8)
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; CI, confidence interval.
a Variations of total count by variable might be caused by “don't know,” refused, or missing responses.
b Chronic conditions included are diabetes, myocardial infarction, heart disease, and current asthma.
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Table 2. Weighted Percentages for Selected Health Behaviors and Preventive Health Care Among Men Aged 40 Years or Older (N = 8,016a) With a History of Pro-









% (95% CI) P Value
Current cigarette smokerb n = 6,867 n = 671 n = 204 n = 222
.005Yes 8.4 (7.3- 9.6) 15.1 (11.7–19.3) 8.0 (3.7–16.7) 15.0 (7.8–26.9)
No 91.6 (90.4–92.7) 84.9 (80.7–88.3) 92.0 (83.3–96.3) 85.0 (73.1–92.2)
Drink >2 alcoholic beverages/d N = 6,767 N = 657 N = 201 N = 218
<.001Yes 3.7 (3.0- 4.4) 0.8 (0.4- 1.8) 1.7 (0.5- 5.5) 7.0 (2.7–17.4)
No 96.3 (95.6–97.0) 99.2 (98.2–99.6) 98.3 (94.5–99.5) 93.0 (82.6–97.3)
Physically inactivec N = 6,900 N = 673 N = 203 N = 224
.13Yes 24.8 (23.2–26.4) 31.1 (25.8–36.9) 32.7 (20.6–47.5) 26.9 (17.3–39.4)
No 75.2 (73.6–76.8) 68.9 (63.1–74.2) 67.3 (52.5–79.4) 73.1 (60.6–82.7)
Body mass index, kg/m2 N = 6,873 N = 662 N = 204 N = 224
.007
<25.0 28.7 (27.0–30.5) 27.4 (21.8–34.0) 39.2 (26.7–53.4) 30.8 (20.6–43.3)
25.0–29.9 48.6 (46.7–50.5) 39.3 (33.5–45.5) 34.5 (22.7–48.6) 44.3 (33.4–55.9)
≥30.0 22.7 (21.1–24.3) 33.2 (27.7–39.2) 26.3 (14.9–42.0) 24.9 (16.2–36.2)
Had influenza vaccination during the
preceding 12 months
N = 6,870 N = 674 N = 203 N = 226
.01Yes 70.3 (68.4–72.0) 63.7 (57.8–69.2) 58.5 (43.9–71.8) 58.0 (46.2–68.9)
No 29.7 (28.0–31.6) 36.3 (30.8–42.2) 41.5 (28.2–56.1) 42.0 (31.1–53.8)
Had pneumococcal vaccination (if  ≥65 y) N = 5407 N = 451 N = 141 N = 154
<.001Yes 74.6 (72.7–76.4) 62.1 (54.5–69.2) 60.2 (41.4–76.4) 50.9 (35.9–65.8)
No 25.4 (23.6–27.3) 37.9 (30.8–45.5) 39.8 (23.6–58.6) 49.1 (34.2–64.1)
Screened for colorectal cancer (if 50–75 y)d N = 3541 N = 426 N = 104 N = 133
.08Yes 84.8 (82.7–86.6) 77.8 (70.6–83.7) 66.0 (42.9–83.4) 77.9 (61.7–88.5)
No 15.2 (13.4–17.3) 22.2 (16.3–29.4) 34.0 (16.6–57.1) 22.1  (11.5–38.3)
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; CI, confidence interval.
a Variations of total count by variable might be caused by “don’t know,” refused, or missing responses.
b Defined as having smoked 100 cigarettes in lifetime and currently smoking.
c Defined by a no response to the question, “During the past month, other than your regular job, did participate in any physical activities or exercise, such as run-
ning, calisthenics, golf, gardening, or walking for exercise?”
d Screened according to US Preventive Services Task Force recommendations (fecal occult blood test within 1 year, sigmoidoscopy within 5 years and fecal occult
blood test within 3 years, or colonoscopy within 10 years).
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Table 3. Multivariate Adjusted Percentagesa of Selected Health Behaviors and Preventive Health Care Among Men Aged 40 Years or Older With a History of Pro-
state Cancer, United States, BRFSS 2010
Characteristic % (95% CI) P Valueb
Current cigarette smokerc
White 9.3 (8.1–10.8) NA
Black 11.2 (8.0–15.4) .37
Other race 7.4 (4.0–13.5) .43
Hispanic 8.9 (5.3–14.7) .87
Drink >2 alcoholic beverages/d
White 3.6 (2.9–4.5) NA
Black 0.9 (0.4- 2.0) <.001
Other race 2.1 (0.6- 6.9) .28
Hispanic 7.2 (3.2–15.4) .22
Physically inactived
White 24.6 (22.9–26.4) NA
Black 27.1 (21.9–32.9) .41
Other race 27.9 (18.3–40.2) .56
Hispanic 22.5 (15.2–32.0) .63
Obese (≥30.0 kg/m2)
White 22.8 (21.1–24.6) NA
Black 29.9 (24.5–35.9) .02
Other race 23.4 (13.1–38.4) .93
Hispanic 22.8 (15.4–32.5) .99
Had influenza vaccination during the preceding 12 months
White 69.8 (67.9–71.8) NA
Black 65.4 (59.1–71.2) .18
Other race 66.1 (51.9–77.9) .58
Hispanic 61.6 (50.0–72.0) .15
Had pneumococcal vaccination (if ≥65 y)
White 74.2 (72.2–76.1) NA
Black 63.2 (54.8–70.8) .009
Other race 61.9 (43.1–77.7) .18
Hispanic 59.8 (41.9–75.4) .11
Screened for colorectal cancer (if 50–75 y)e
White 82.5 (80.7–84.1) NA
Abbreviations: BRFSS: Behavioral Risk Factor Surveillance System; CI: confidence interval; NA, not applicable.
aAdjusted for age, education, employment, marital status, health insurance, time since last checkup, medical cost concern, usual health care provider, emotional
support, diabetes, myocardial infarction, heart disease, asthma, and disabilities.
b P values for pairwise comparisons with whites are based on Wald F statistics.
c Defined as having smoked 100 cigarettes in lifetime and currently smoking.
d Defined by a no response to the question, “During the past month, other than your regular job, did participate in any physical activities or exercise, such as run-
ning, calisthenics, golf, gardening, or walking for exercise?”
e Screened according to US Preventive Services Task Force recommendations (fecal occult blood test within 1 year, sigmoidoscopy within 5 years and fecal occult
blood test within 3 years, or colonoscopy within 10 years).
(continued on next page)
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(continued)
Table 3. Multivariate Adjusted Percentagesa of Selected Health Behaviors and Preventive Health Care Among Men Aged 40 Years or Older With a History of Pro-
state Cancer, United States, BRFSS 2010
Characteristic % (95% CI) P Valueb
Black 81.2 (76.1–85.5) .62
Other race 74.9 (52.4–89.0) .43
Hispanic 81.6 (72.5–88.2) .83
Abbreviations: BRFSS: Behavioral Risk Factor Surveillance System; CI: confidence interval; NA, not applicable.
aAdjusted for age, education, employment, marital status, health insurance, time since last checkup, medical cost concern, usual health care provider, emotional
support, diabetes, myocardial infarction, heart disease, asthma, and disabilities.
b P values for pairwise comparisons with whites are based on Wald F statistics.
c Defined as having smoked 100 cigarettes in lifetime and currently smoking.
d Defined by a no response to the question, “During the past month, other than your regular job, did participate in any physical activities or exercise, such as run-
ning, calisthenics, golf, gardening, or walking for exercise?”
e Screened according to US Preventive Services Task Force recommendations (fecal occult blood test within 1 year, sigmoidoscopy within 5 years and fecal occult
blood test within 3 years, or colonoscopy within 10 years).
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